Investor Area

Home / Investor Area / News / Sachs 18th Biotech in Europe Forum Presentation

Sachs 18th Biotech in Europe Forum Presentation

08 October 2018

 

CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL DESIGNATION: CLVLY) presented at the Sachs 18th Biotech in Europe Forum on Thursday 04 October. A copy of the presentation is appended.

 

Download PDF for more